Back to RGNX
MARSHALL WACE, LLP RGNX Position History
REGENXBIO Inc. • Healthcare
Quarters held
9
Latest value
$6.2M
Q3 2026
Peak value
$15.1M
First seen
Q3 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2023 | $547K |
| Q2 2024 | $457K |
| Q1 2025 | $36K |
| Q1 2025 | $1.6M |
| Q2 2025 | $1.8M |
| Q2 2026 | $339K |
| Q2 2026 | $15.1M |
| Q3 2026 | $457K |
| Q3 2026 | $6.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $6.2M | 817.9K | — | — |
| Q3 2026 | $457K | 60.7K | — | — |
| Q2 2026 | $15.1M | 1.26M | — | — |
| Q2 2026 | $339K | 28.3K | — | — |
| Q2 2025 | $1.8M | 222.3K | — | — |
| Q1 2025 | $1.6M | 220.5K | — | — |
| Q1 2025 | $36K | 5.0K | — | — |
| Q2 2024 | $457K | 39.1K | — | — |
| Q3 2023 | $547K | 33.2K | — | — |
Other funds holding RGNX
$106.8M
$92.2M
$65.8M
$63.7M
$62.9M
$52.3M
$47.2M